Portfolio company
JUMPCODE Genomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops CRISPR-based reagent kits that remove unwanted genetic sequences from sequencing libraries for researchers in oncology, infectious disease and basic research.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
Swift Biosciences
This company develops next-generation sequencing library preparation kits for researchers in academic, translational and clinical laboratories.
ArgenTAG
This company develops single-cell genomic sequencing kits and barcoding technology for researchers to analyse complex biological data using long-read sequencing platforms.
Arima Genomics
This company develops 3D genomic sequencing kits and clinical diagnostic tests for researchers and pharmaceutical companies to identify cancer-driving genetic alterations.
CS Genetics
This company develops instrument-free single-cell genomics kits for academic researchers and biopharmaceutical organisations to perform transcriptomics without expensive hardware.
Population Genetics
This company develops molecular and sample barcoding technology to enable cost-effective next-generation sequencing of large DNA populations for clinical and research laboratories.
Ultima Genomics
This company develops and manufactures high-throughput DNA sequencing platforms for researchers and clinicians performing population-scale genomic analysis.
Phase Genomics
Phase Genomics develops proximity ligation kits and computational tools for genome assembly and metagenomic analysis used by researchers in oncology, agriculture and microbiology.
